Close Menu
Home › Prescient Medicine, Metabiomics Form GI Dx Partnership

Prescient Medicine, Metabiomics Form GI Dx Partnership

Sep 18, 2018
|
staff reporter

NEW YORK (GenomeWeb) — Prescient Medicine — a provider of toxicology, pharmacogenomic, and other testing services — has partnered with Metabiomics to develop microbiome diagnostic assays for colon cancer and other gastrointestinal diseases, the companies said today.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jan
28
Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of FLT3 and CEBPA

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Feb
05
Featured Webinar

Development of a Novel Multiplex Assay: A Partnership Case Study

Sponsored by
LGC

This webinar will provide a behind-the-scenes look at the collaborative development of a novel multiplex assay to speed detection of mosquito-borne illness in the clinical setting.

What's Popular?

In Business News

  1. JP Morgan Healthcare Day One: Qiagen, Guardant Health, Bio-Rad, Hologic, Myriad Genetics

  2. JP Morgan Healthcare Day 4: Biocartis, Oxford Immunotec

  3. JP Morgan Healthcare Day 2: Abbott, Caris, Danaher, Quest, LabCorp, Luminex, Agilent, Adaptive Bio

  4. Color Raises $75M to Scale Infrastructure

  5. Roche, Illumina Partner on Next-Generation Sequencing IVD, CDx Development, Marketing

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.